Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1961 1
1962 1
1963 1
1965 1
1967 1
1987 1
1988 4
1989 2
1990 3
1991 1
1993 1
1995 1
1996 2
1999 2
2000 4
2001 2
2002 3
2003 2
2006 1
2007 2
2008 4
2009 6
2010 8
2011 13
2012 9
2013 10
2014 5
2015 3
2016 12
2017 5
2018 16
2019 17
2020 14
2021 20
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.
Pillay N, Tighe A, Nelson L, Littler S, Coulson-Gilmer C, Bah N, Golder A, Bakker B, Spierings DCJ, James DI, Smith KM, Jordan AM, Morgan RD, Ogilvie DJ, Foijer F, Jackson DA, Taylor SS. Pillay N, et al. Among authors: morgan rd. Cancer Cell. 2019 Mar 18;35(3):519-533.e8. doi: 10.1016/j.ccell.2019.02.004. Cancer Cell. 2019. PMID: 30889383 Free PMC article.
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Morgan RD, McNeish IA, Cook AD, James EC, Lord R, Dark G, Glasspool RM, Krell J, Parkinson C, Poole CJ, Hall M, Gallardo-Rincón D, Lockley M, Essapen S, Summers J, Anand A, Zachariah A, Williams S, Jones R, Scatchard K, Walther A, Kim JW, Sundar S, Jayson GC, Ledermann JA, Clamp AR. Morgan RD, et al. Lancet Oncol. 2021 Feb;22(2):277-288. doi: 10.1016/S1470-2045(20)30591-X. Epub 2020 Dec 22. Lancet Oncol. 2021. PMID: 33357510 Clinical Trial.
Engineering altered protein-DNA recognition specificity.
Bogdanove AJ, Bohm A, Miller JC, Morgan RD, Stoddard BL. Bogdanove AJ, et al. Among authors: morgan rd. Nucleic Acids Res. 2018 Jun 1;46(10):4845-4871. doi: 10.1093/nar/gky289. Nucleic Acids Res. 2018. PMID: 29718463 Free PMC article. Review.
A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes.
Roberts RJ, Belfort M, Bestor T, Bhagwat AS, Bickle TA, Bitinaite J, Blumenthal RM, Degtyarev SKh, Dryden DT, Dybvig K, Firman K, Gromova ES, Gumport RI, Halford SE, Hattman S, Heitman J, Hornby DP, Janulaitis A, Jeltsch A, Josephsen J, Kiss A, Klaenhammer TR, Kobayashi I, Kong H, Krüger DH, Lacks S, Marinus MG, Miyahara M, Morgan RD, Murray NE, Nagaraja V, Piekarowicz A, Pingoud A, Raleigh E, Rao DN, Reich N, Repin VE, Selker EU, Shaw PC, Stein DC, Stoddard BL, Szybalski W, Trautner TA, Van Etten JL, Vitor JM, Wilson GG, Xu SY. Roberts RJ, et al. Among authors: morgan rd. Nucleic Acids Res. 2003 Apr 1;31(7):1805-12. doi: 10.1093/nar/gkg274. Nucleic Acids Res. 2003. PMID: 12654995 Free PMC article.
First-Line Management of Advanced High-Grade Serous Ovarian Cancer.
Mahmood RD, Morgan RD, Edmondson RJ, Clamp AR, Jayson GC. Mahmood RD, et al. Among authors: morgan rd. Curr Oncol Rep. 2020 Jun 4;22(6):64. doi: 10.1007/s11912-020-00933-8. Curr Oncol Rep. 2020. PMID: 32494876 Free PMC article. Review.
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.
Morgan RD, Clamp AR, Evans DGR, Edmondson RJ, Jayson GC. Morgan RD, et al. Cancer Chemother Pharmacol. 2018 Apr;81(4):647-658. doi: 10.1007/s00280-018-3532-9. Epub 2018 Feb 20. Cancer Chemother Pharmacol. 2018. PMID: 29464354 Free PMC article. Review.
The non-specific adenine DNA methyltransferase M.EcoGII.
Murray IA, Morgan RD, Luyten Y, Fomenkov A, Corrêa IR Jr, Dai N, Allaw MB, Zhang X, Cheng X, Roberts RJ. Murray IA, et al. Among authors: morgan rd. Nucleic Acids Res. 2018 Jan 25;46(2):840-848. doi: 10.1093/nar/gkx1191. Nucleic Acids Res. 2018. PMID: 29228259 Free PMC article.
154 results